5 terminated. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
| Phase 2 | 2 | Terminated 2 |
Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC M7824, Placebo, Gemcitabine - Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 / Phase 3 | Terminated | EMD Serono Research & Development Institute, Inc. | 309 | 2019-09-20 | 2023-11-14 |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer capecitabine, gemcitabine hydrochloride, quality-of-life assessment - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 3 | Terminated | NCIC Clinical Trials Group | 19 | 2008-10-10 | 2023-08-04 |
| Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo AMT2003 - Gastrointestinal Cancer, Prostate Cancer | Phase 2 / Phase 3 | Terminated | Auron Healthcare GmbH | 67 | 2006-05-01 | 2013-03-20 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer escitalopram oxalate, Placebo - Colorectal Cancer, Depression | Phase 3 | Terminated | Massachusetts General Hospital | 24 | 2006-03-01 | 2012-12-03 |
| XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors becatecarin, 5-Fluorouracil Plus Leucovorin - Biliary Tract Cancer | Phase 3 | Terminated | Helsinn Healthcare SA | 248 | 2004-09-01 | 2009-01-14 |
Gallbladder Neoplasms (5) · Bile Duct Neoplasms (3) · Liver Neoplasms (3) · Biliary Tract Neoplasms (2) · Cholangiocarcinoma (2) · Colonic Neoplasms (2) · Esophageal Neoplasms (2) · Lung Neoplasms (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Camurati-Engelmann Syndrome (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Depression (1)
Biliary Tract Diseases (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Neoplasms (5) · Neoplasms by Site (5) · Adenocarcinoma (3) · Bile Duct Diseases (3) · Biliary Tract Neoplasms (3) · Carcinoma (3) · Liver Diseases (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2)
Gemcitabine (2) · Capecitabine (1) · Cisplatin (1) · Escitalopram (1) · Fluorouracil (1) · Leucovorin (1) · becatecarin (1)
Auron Healthcare GmbH (1) · EMD Serono Research & Development Institute, Inc. (1) · Helsinn Healthcare SA (1) · Massachusetts General Hospital (1) · NCIC Clinical Trials Group (1)
Germany (3) · United States (3) · Canada (2) · France (2) · Italy (2) · Poland (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Bosnia and Herzegovina (1) · Brazil (1) · Chile (1) · China (1)
Afshin Dowlati, MD (1) · Jennifer Knox, MD (1) · Joachim Drevs, PD Dr. Med (1) · William F. Pirl, MD (1)
2019 (1), K23CA115908 (1)